Zobrazeno 1 - 10
of 339
pro vyhledávání: '"Vinod, Pullarkat"'
Autor:
David Dingli, Carlos De Castro III, Jamie Koprivnikar, Austin Kulasekararaj, Jaroslaw Maciejewski, Brian Mulherin, Jens Panse, Vinod Pullarkat, Alexander Röth, Jamile Shammo, Louis Terriou, Ilene Weitz, Irina Yermilov, Sarah Gibbs, Michael Broder, David Beenhouwer, David Kuter
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTIntroduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, non-malignant hematologic disease characterized by complement-mediated hemolysis (with or without hemoglobinuria), fatigue, increased susceptibility to thrombosis, a
Externí odkaz:
https://doaj.org/article/9910639b99bf41af8dfaccc4685e89c0
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a 1:5 molar ratio, is approved for the treatment of newly diagnosed therapy-related acute myeloid leukemia (AML) or AML with myelodysplasia-related changes. In a pivotal p
Externí odkaz:
https://doaj.org/article/1cda4855cb34403eb6a598e66a41608c
Autor:
Antonio Maria Risitano, Alexander Röth, Austin Kulasekararaj, Phillip Scheinberg, Yasutaka Ueda, Carlos de Castro, Eros DI Bona, Morag Griffin, Saskia Langemeijer, Hubert Schrezenmeier, Wilma Barcellini, Vitor Aq Mauad, Jens Panse, Philippe Schafhausen, Suzanne Tavitian, Eloise Beggiato, Anna Gaya, Wei-Han Huang, Toshio Kitawaki, Abdullah Kutlar, Jaroslaw P Maciejewski, Rosario Notaro, Vinod Pullarkat, Jörg Schubert, Louis Terriou, Michihiro Uchiyama, Flore Sicre de Fontbrune, Luana Marano, Ferras Alashkar, Shreyans Gandhi, Cécile Kerloëguen, Rakesh Kumar, Christine Thorburn, Samopriyo Maitra, Marion Dahlke, Régis Peffault de Latour
Publikováno v:
HemaSphere, Vol 7, p e29006c9 (2023)
Externí odkaz:
https://doaj.org/article/efa1233f722549f49a84c98218df9720
Autor:
Keith Pratz, Courtney Dinardo, Martha L Arellano, Michael Thirman, Vinod Pullarkat, Pamela S. Becker, B. Douglas Smith, Meng Zhang, Michael E Werner, Jalaja Potluri, Daniel A. Pollyea
Publikováno v:
HemaSphere, Vol 7, p e68978fe (2023)
Externí odkaz:
https://doaj.org/article/9d932cfaecc64a378a4df2ef7714d55c
Autor:
Yuexi Wang, Ann Marie Mcneill, Charlotte Doran, Lauren Cain, Yangyang Liu, Ziyu Lan, Wei-Han Chang, Vinod Pullarkat
Publikováno v:
HemaSphere, Vol 7, p e5986813 (2023)
Externí odkaz:
https://doaj.org/article/47fd450fe3ba40de85f4ac2235dfaa69
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Blinatumomab is a bispecific T cell engager that has shown efficacy in relapsed/refractory Philadelphia chromosome (Ph)-positive and Ph-negative acute lymphoblastic leukemia (ALL). Considering its favorable safety and activity in advanced ALL, blinat
Externí odkaz:
https://doaj.org/article/a31bfad658e04c3ea8b82f9ed2acaeae
Autor:
Ibrahim Aldoss, Raju Pillai, Dongyun Yang, Lixin Yang, Shukaib Arslan, Sally Mokhtari, Monzr M. Al Malki, Amandeep Salhotra, Shilpa Shahani, Haris Ali, Matthew Mei, Andrew Artz, David Snyder, Michelle Afkhami, Saro Armenian, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/e4e4b6a679c44c52940d83c8d0470e91
Autor:
Ralf Buettner, Le Xuan Truong Nguyen, Corey Morales, Min-Hsuan Chen, Xiwei Wu, Lisa S. Chen, Dinh Hoa Hoang, Servando Hernandez Vargas, Vinod Pullarkat, Varsha Gandhi, Guido Marcucci, Steven T. Rosen
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-16 (2021)
Abstract Background BCL‐2 inhibition through venetoclax (VEN) targets acute myeloid leukemia (AML) blast cells and leukemic stem cells (LSCs). Although VEN-containing regimens yield 60–70% clinical response rates, the vast majority of patients in
Externí odkaz:
https://doaj.org/article/79107741b5c5447d8ccfb700eb63b9aa
Autor:
Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. Wasser, David Beenhouwer, Sarah N. Gibbs, Irina Yermilov, Michael S. Broder
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 69-80 (2021)
Abstract Background Thrombopoietin receptor agonists (TPO‐RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count. Objectives To develop expert consensus
Externí odkaz:
https://doaj.org/article/227a3e2d261045778633731119f64d14
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 10, Pp 2341-2348 (2020)
The IL-3 alpha chain receptor (CD123) is a cell surface protein that is widely expressed by various subtypes of acute leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia and blastic plasmacytoid dendritic cell neoplasm. Not
Externí odkaz:
https://doaj.org/article/9dd48113ae204c0ba0d65248fa4a45fb